RS58800B1 - Kompozicije za upotrebu u onkologiji - Google Patents

Kompozicije za upotrebu u onkologiji

Info

Publication number
RS58800B1
RS58800B1 RS20190657A RSP20190657A RS58800B1 RS 58800 B1 RS58800 B1 RS 58800B1 RS 20190657 A RS20190657 A RS 20190657A RS P20190657 A RSP20190657 A RS P20190657A RS 58800 B1 RS58800 B1 RS 58800B1
Authority
RS
Serbia
Prior art keywords
oncology
compositions
Prior art date
Application number
RS20190657A
Other languages
English (en)
Inventor
Laurence Poul
Laurent Levy
Céline Berjaud
Matthieu Germain
Agnès Pottier
Original Assignee
Nanobiotix
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanobiotix filed Critical Nanobiotix
Publication of RS58800B1 publication Critical patent/RS58800B1/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A61K49/0414—Particles, beads, capsules or spheres
    • A61K49/0423—Nanoparticles, nanobeads, nanospheres, nanocapsules, i.e. having a size or diameter smaller than 1 micrometer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0457—Semi-solid forms, ointments, gels, hydrogels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
RS20190657A 2013-06-20 2014-06-19 Kompozicije za upotrebu u onkologiji RS58800B1 (sr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361837406P 2013-06-20 2013-06-20
EP13305830 2013-06-20
PCT/EP2014/062976 WO2014202738A1 (en) 2013-06-20 2014-06-19 Compositions and methods for use in oncology
EP14731952.9A EP3010552B1 (en) 2013-06-20 2014-06-19 Compositions for use in oncology

Publications (1)

Publication Number Publication Date
RS58800B1 true RS58800B1 (sr) 2019-07-31

Family

ID=48741003

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20190657A RS58800B1 (sr) 2013-06-20 2014-06-19 Kompozicije za upotrebu u onkologiji

Country Status (18)

Country Link
US (1) US20160136304A1 (sr)
EP (1) EP3010552B1 (sr)
JP (1) JP6484229B2 (sr)
KR (1) KR102217217B1 (sr)
CN (1) CN105431174B (sr)
AU (1) AU2014283232B2 (sr)
BR (1) BR112015031984A2 (sr)
CA (1) CA2915145C (sr)
CY (1) CY1121770T1 (sr)
EA (1) EA033792B1 (sr)
HK (1) HK1222561A1 (sr)
MA (1) MA38710A1 (sr)
MX (1) MX2015017780A (sr)
PL (1) PL3010552T3 (sr)
RS (1) RS58800B1 (sr)
SG (1) SG11201510468TA (sr)
SI (1) SI3010552T1 (sr)
WO (1) WO2014202738A1 (sr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10945965B2 (en) 2011-12-16 2021-03-16 Nanobiotix Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof
KR20160027009A (ko) * 2013-06-20 2016-03-09 나노비오띡스 의학적 진단에 사용되는 조성물 및 방법
CN107708668A (zh) 2015-05-28 2018-02-16 纳米生物技术公司 用作治疗性疫苗的纳米粒子
US9607952B1 (en) * 2015-10-30 2017-03-28 International Business Machines Corporation High-z oxide nanoparticles embedded in semiconductor package
CN113842395B (zh) * 2021-10-15 2022-12-23 中国科学院高能物理研究所 钽纳米复合物及包含该钽纳米复合物的淋巴示踪剂、放疗增敏剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5370901A (en) * 1991-02-15 1994-12-06 Bracco International B.V. Compositions for increasing the image contrast in diagnostic investigations of the digestive tract of patients
FR2869803B1 (fr) * 2004-05-10 2006-07-28 Nanobiotix Sarl Particules activables, preparation et utilisations
EP1942950A2 (en) * 2005-11-01 2008-07-16 Yissum Research Development Company Of The Hebrew University Of Jerusalem Biodegradable composite for internal local radiotherapy
US8043005B2 (en) * 2006-06-02 2011-10-25 Hydrapak, Inc. Reservoir closure system and method
CA3149284A1 (en) * 2009-12-15 2011-07-14 Incept, Llc Implants and biodegradable fiducial markers

Also Published As

Publication number Publication date
EA033792B1 (ru) 2019-11-26
CY1121770T1 (el) 2020-07-31
CN105431174A (zh) 2016-03-23
EP3010552A1 (en) 2016-04-27
AU2014283232A1 (en) 2016-01-21
PL3010552T3 (pl) 2019-09-30
CN105431174B (zh) 2019-06-07
WO2014202738A1 (en) 2014-12-24
JP2016523244A (ja) 2016-08-08
EP3010552B1 (en) 2019-04-17
CA2915145C (en) 2021-06-08
CA2915145A1 (en) 2014-12-24
EA201690042A1 (ru) 2016-06-30
MA38710A1 (fr) 2017-12-29
AU2014283232B2 (en) 2019-03-28
SG11201510468TA (en) 2016-01-28
KR20160027011A (ko) 2016-03-09
JP6484229B2 (ja) 2019-03-13
HK1222561A1 (zh) 2017-07-07
BR112015031984A2 (pt) 2017-07-25
KR102217217B1 (ko) 2021-02-18
US20160136304A1 (en) 2016-05-19
SI3010552T1 (sl) 2019-08-30
MX2015017780A (es) 2016-07-06

Similar Documents

Publication Publication Date Title
PL3065569T3 (pl) Kompozycja
EP2889350A4 (en) ADHESIVE COMPOSITION
HK1214088A1 (zh) 油脂組合物
HUE044039T2 (hu) Biokatalitikus készítmény
EP3006525A4 (en) ASPHALT-URETHANE COMPOSITION
GB201319540D0 (en) Composition
GB201318489D0 (en) Composition
GB201317388D0 (en) Composition
GB201320919D0 (en) Composition
EP3066178A4 (en) GREASE COMPOSITION
GB201322772D0 (en) Composition
GB201319538D0 (en) Composition
GB201306984D0 (en) Composition
HK1222561A1 (zh) 用於腫瘤學的組合物和方法
GB201320303D0 (en) Composition
GB201317196D0 (en) Composition
GB201307622D0 (en) Composition
GB201420672D0 (en) Composition
GB201308502D0 (en) Composition
GB201301774D0 (en) Composition
GB201318394D0 (en) Composition
LT3010552T (lt) Kompozicijos, skirtos naudoti onkologijoje
GB201320675D0 (en) Composition
GB201305622D0 (en) Composition
SI3082855T1 (sl) Sestavek